Valquest Partners
VC Fund
Beirut, Lebanon
Valquest Partners is a VC fund in Beirut focused on Biotechnology and Chemical. By leveraging its partners’ substantial financial, operational, transactional, and industry resources and related experience,
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Valquest Partners invests in
Stages Valquest Partners invests in
Countries Valquest Partners invests in
Round sizes
Round size
- Series A
- $15M–$15M
- Venture - Series Unknown
- $7.6M–$24M
Investment Focus
Industry
- Biotechnology 3 (60%)
- Chemical 2 (40%)
- Energy 1 (20%)
- Biopharma 1 (20%)
- CleanTech 1 (20%)
Stage
- Venture - Series Unknown 2 (40%)
- Series A 1 (20%)
- Series B 1 (20%)
Country
- France 2 (40%)
- Sweden 1 (20%)
- Switzerland 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide. | $7.6M / Venture - Series Unknown / Sep 22, 2026 | ||
| Bloom Biorenewables is creating a global impact in the use of sustainable resources. By introducing a new route for the production of biorenewable products and fuels, they offer a sustainable alternative to fossil-based industries and contribute to mitigating climate change. | $14.8M / Series A / Apr 02, 2025 | ||
| TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bindstrongly to tissues, and deliver on-demand wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC, and CapDecisif Management. | $43.2M / Series B / Nov 20, 2019 | ||
| AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment. | $23.8M / Venture - Series Unknown / Feb 12, 2019 | ||
| See all 5 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Valquest Partners invest in?
Valquest Partners invests primarily in Biotechnology, Chemical and Energy startups, most often at Venture - Series Unknown and Series A stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Valquest Partners invest in?
Valquest Partners typically joins rounds of $15M–$15M at Series A and $7.6M–$24M at Venture - Series Unknown. These are whole funding-round sizes, not Valquest Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Valquest Partners took part in.
When did Valquest Partners last invest?
The most recent investment recorded for Valquest Partners closed in Sep 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
